Hurum Co Ltd

Hurum Co Ltd maintains a liquidity position with a current ratio of 1.65, indicating moderate short-term solvency, and a price-to-book ratio of 0.59, suggesting the market values the company at a discount to its book value. The company's cash and equivalents amount to KRW 19,930,981,650, but this is offset by long-term debt of KRW 33,643,691,760, resulting in a negative net cash position. Profitability metrics show a return on equity (ROE) of 2.72% and a return on assets (ROA) of 1.17%, both below the industry_config preferred metrics for Food Processing firms, which typically require ROE above 10% and ROA above 5% to be considered competitive. The company's operating margin is 1.90% (KRW 1,874,979,920 operating income on KRW 99,011,416,960 revenue), which is significantly lower than the cohort median of 8.5%. Geographically, Hurum Co Ltd is concentrated in the Korean market, with all revenue derived from domestic operations. The company's product segments are primarily health functional foods and lactic acid bacteria products, with no disclosed international revenue or diversification into other product lines. This concentration increases exposure to local economic and regulatory shifts. The company's growth trajectory is modest, with no disclosed revenue growth in the latest period. The outlook for the current fiscal year (FY) and the next FY is neutral, with no significant revenue or margin expansion expected. Historical revenue has remained flat, and the company's capital expenditures (KRW -2,713,925,750) suggest a focus on cost optimization rather than expansion. Risk factors include a medium liquidity risk due to the negative net cash position and a debt-to-equity ratio of 0.79, which is relatively high for a Food Processing firm. The risk assessment indicates low dilution potential, with shares outstanding remaining unchanged between basic and diluted measures. However, the company's free cash flow of KRW 925,919,810 is insufficient to cover long-term debt servicing, which could necessitate future financing. Recent events include no material filings or transcripts in the latest period. The company's 10-K Risk Factors section highlights potential regulatory changes in the health functional foods sector, which could impact product approvals and market access. No recent earnings calls or investor presentations have been disclosed.